Xiangyu Medical: BCI Products Deployed in Over 500 Tier-3A Hospitals, Targeting 700+ by Chinese New Year

Source: Cailian Press

【Sunnyou Medical【Products Related to Brain-Computer Interface Have Entered Over 500 Top Tier-3 Hospitals in China, Expected to Reach Over 700 Before the Spring Festival】Cailian Press, December 22 — Xiangyu Medical (688626.SH) disclosed records of investor relations activities. Up to now, the sales generated by brain-computer interface-related products are still relatively small; the company expects rapid growth in sales revenue from these products by 2026. In terms of product layout for brain-computer interfaces, the company has released about 14 new products and is expected to launch nearly 30 new products before the Spring Festival. To date, the company's brain-computer interface-related products have entered more than 500 top tier-3 hospitals in China, with a target of entering over 700 before the Spring Festival and a goal of reaching 1,500 top tier-3 hospitals across China next year. The company’s technological approach in the brain-computer interface field focuses mainly on non-invasive methods while planning to integrate and upgrade currently mature invasive and non-invasive technologies. Additionally, the company has started laying out some consumer-grade products, focusing on "downgrading" rehabilitation techniques used in medical institutions for application in home environments.